Conference Series
Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths.
London and Singapore (PRWEB) December 29, 2017
Oncology Conferences are intended to provide a medium for the communication of results and ideas in the field of cancer science and Treatment. The conference welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for Innovative topics related to the cancer science. Oncology meetings offer the diagnosis, prevention and treatment of cancer from the foremost experts in the field.
Oncology conferences are exceptionally efficient logical events comprising exhibitions of cutting edge hardware's innovation, oncology instruments, and Oncology workshops, symposiums, unique sessions for specialists and under graduates.
Dr Srinubabu Gedela told in an occation, Oncology conference has flourished tremendously over the past 6 years; however, Cancer is the leading cause of death. The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).
global oncology markets reached $15.8 billion in 2011. According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths.
According the oncology market in United States The current report provides state-specific and regional data for cancer cases diagnosed and for cancer deaths in US regions that occurred in 2014, the most recent year for which incidence data are available..
Oncology market in the Europe, The Market value for the Cancer research in Europe in 2012 is 6.5$ billion and for 2016 will be raise to 10.2$ billion and for 2016 raises to 3.9$ billion and Market value for all over the world in 2012 is 54$ billion and for 2016 it will be raises to 81$ billion.
In 2010, the global cancer market was valued at $54 billion, with forecasted Compound Annual Growth Rate (CAGR) growth to $81 billion by 2016.
In the region of Asia-pacific, There are 3.6 million males and 4.0 million females living with cancer in these Asian countries;China alone has 1.6 million male and 1.5 million female cancer survivors. The magnitude of the surviving population is a function of incidence rates—new cases diagnosed during the year—as well as associated mortality rates. Although the United States has a much smaller population than China (303 million), it has 50% more cancer survivors (2.4 million males and 2.3 million females living with cancer).
According to Middle East cancer market Industry measurements and market estimate is yearly $4bn. Number of men encountering dermatological illness is 35 Million, number of ladies encountering dermatological malady is 21 Million, number of male pattern baldness sufferers, looking for proficient treatment is 811,363.
Conference Series organizes a series of 3000+ Global Events inclusive of 1000+ Conferences, 2000+ Symposiums and Workshops in America, Europe and Asia with support from 1000 more scientific societies and publishes 1000+ Omics Group peer reviewed Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Program Director
Oncology Conferences series
702-508-5200 (8050)
Email: contact(at)confereceseries(dot)com